Literature DB >> 20206723

Current status and advances in management of early breast cancer.

M Keshtgar1, T Davidson, K Pigott, M Falzon, A Jones.   

Abstract

Breast cancer is the most common female cancer. Worldwide, more than a million women are diagnosed every year. However despite this increase, the mortality rate is declining. This is due to combination of factors including early diagnosis and effective treatment. This manuscript which is presented in two sections outlines the current status in management of early breast cancer. Section 1 focuses on the advances in diagnosis and surgical treatment of breast cancer and give an overview of the histopathological aspects. The focus of section 2 is on advances on adjuvant treatment of breast cancer including radiotherapy, chemotherapy and endocrine treatment. Copyright 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20206723     DOI: 10.1016/j.ijsu.2010.02.004

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  4 in total

1.  Intraoperative radiation therapy deserves to be made more readily available to patients.

Authors:  Mohammed Keshtgar; Norman R Williams
Journal:  Chin J Cancer Res       Date:  2016-08       Impact factor: 5.087

Review 2.  Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.

Authors:  Anoop K Yadav; Neetin S Desai
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

3.  Pregnancy-associated plasma protein-A (PAPPA) promotes breast cancer progression.

Authors:  Jun Zhang; Yuan Zhang; Lanjiang Li; Yinghua Nian; Ying Chen; Ruoxia Shen; Xiaoyan Ma
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

Review 4.  Intraoperative radiotherapy for breast cancer.

Authors:  Norman R Williams; Katharine H Pigott; Chris Brew-Graves; Mohammed R S Keshtgar
Journal:  Gland Surg       Date:  2014-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.